IVIG-SN

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IVIG-SN, covering 2012-09-20 to 2014-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency [Phase 3]